- Home
- SRTS vs ME Comparison
SRTS vs ME Comparison
Compare SRTS & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- ME
- Stock Information
- Founded
- SRTS 2010
- ME 2006
- Country
- SRTS United States
- ME United States
- Employees
- SRTS N/A
- ME N/A
- Industry
- SRTS Medical/Dental Instruments
- ME Precision Instruments
- Sector
- SRTS Health Care
- ME Health Care
- Exchange
- SRTS Nasdaq
- ME Nasdaq
- Market Cap
- SRTS 118.2M
- ME 98.7M
- IPO Year
- SRTS 2016
- ME N/A
- Fundamental
- Price
- SRTS $6.77
- ME $3.49
- Analyst Decision
- SRTS Strong Buy
- ME Hold
- Analyst Count
- SRTS 2
- ME 1
- Target Price
- SRTS $12.50
- ME $9.40
- AVG Volume (30 Days)
- SRTS 244.3K
- ME 219.4K
- Earning Date
- SRTS 02-06-2025
- ME 02-05-2025
- Dividend Yield
- SRTS N/A
- ME N/A
- EPS Growth
- SRTS N/A
- ME N/A
- EPS
- SRTS 0.57
- ME N/A
- Revenue
- SRTS $41,308,000.00
- ME $193,260,000.00
- Revenue This Year
- SRTS $65.04
- ME $21.93
- Revenue Next Year
- SRTS $24.87
- ME $17.31
- P/E Ratio
- SRTS $11.51
- ME N/A
- Revenue Growth
- SRTS 65.62
- ME N/A
- 52 Week Low
- SRTS $2.61
- ME $2.66
- 52 Week High
- SRTS $9.33
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- SRTS 40.52
- ME 47.12
- Support Level
- SRTS $6.38
- ME $3.37
- Resistance Level
- SRTS $7.62
- ME $4.18
- Average True Range (ATR)
- SRTS 0.43
- ME 0.26
- MACD
- SRTS -0.05
- ME 0.03
- Stochastic Oscillator
- SRTS 29.55
- ME 37.95
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.